Rachel M. Bennett

Array ( [id] => 6729578 [patent_doc_number] => 20030185768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Method of treating periodontal disease' [patent_app_type] => new [patent_app_number] => 10/405296 [patent_app_country] => US [patent_app_date] => 2003-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3599 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20030185768.pdf [firstpage_image] =>[orig_patent_app_number] => 10405296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395535 [patent_doc_number] => 20040022759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Ionic polymers as anti-infective agents' [patent_app_type] => new [patent_app_number] => 10/374014 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9853 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022759.pdf [firstpage_image] =>[orig_patent_app_number] => 10374014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1144368 [patent_doc_number] => 06773714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-10 [patent_title] => 'Polymeric delivery formulations of leuprolide with improved efficacy' [patent_app_type] => B2 [patent_app_number] => 10/373400 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7268 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/773/06773714.pdf [firstpage_image] =>[orig_patent_app_number] => 10373400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6710555 [patent_doc_number] => 20030170304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Multiparticulate modified release composition' [patent_app_type] => new [patent_app_number] => 10/354483 [patent_app_country] => US [patent_app_date] => 2003-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7626 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170304.pdf [firstpage_image] =>[orig_patent_app_number] => 10354483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6855736 [patent_doc_number] => 20030129237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Multiparticulate modified release composition' [patent_app_type] => new [patent_app_number] => 10/331754 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7634 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129237.pdf [firstpage_image] =>[orig_patent_app_number] => 10331754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792549 [patent_doc_number] => 20030087893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Compositions containing alpha-2-adrenergic agonist components' [patent_app_type] => new [patent_app_number] => 10/299386 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7887 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087893.pdf [firstpage_image] =>[orig_patent_app_number] => 10299386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787254 [patent_doc_number] => 20030138493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same' [patent_app_type] => new [patent_app_number] => 10/264793 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 21977 [patent_no_of_claims] => 206 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138493.pdf [firstpage_image] =>[orig_patent_app_number] => 10264793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1255570 [patent_doc_number] => 06667061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-23 [patent_title] => 'Preparation of injectable suspensions having improved injectability' [patent_app_type] => B2 [patent_app_number] => 10/259949 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9047 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/667/06667061.pdf [firstpage_image] =>[orig_patent_app_number] => 10259949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1222904 [patent_doc_number] => 06699491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-02 [patent_title] => 'Method for modulating glutamate and/or aspartate release in a central nervous system locus' [patent_app_type] => B2 [patent_app_number] => 10/256691 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6981 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699491.pdf [firstpage_image] =>[orig_patent_app_number] => 10256691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1245181 [patent_doc_number] => 06676972 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-13 [patent_title] => 'Covalent microparticle-drug conjugates for biological targeting' [patent_app_type] => B2 [patent_app_number] => 10/237846 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16844 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/676/06676972.pdf [firstpage_image] =>[orig_patent_app_number] => 10237846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1279049 [patent_doc_number] => 06641834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-04 [patent_title] => 'Compositions containing alpha-2-adrenergic agonist components' [patent_app_type] => B2 [patent_app_number] => 10/236566 [patent_app_country] => US [patent_app_date] => 2002-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7804 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/641/06641834.pdf [firstpage_image] =>[orig_patent_app_number] => 10236566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6324296 [patent_doc_number] => 20020197312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications' [patent_app_type] => new [patent_app_number] => 10/188680 [patent_app_country] => US [patent_app_date] => 2002-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2825 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20020197312.pdf [firstpage_image] =>[orig_patent_app_number] => 10188680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6755352 [patent_doc_number] => 20030003129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Ophthalmic drug delivery device' [patent_app_type] => new [patent_app_number] => 10/187006 [patent_app_country] => US [patent_app_date] => 2002-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6816 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20030003129.pdf [firstpage_image] =>[orig_patent_app_number] => 10187006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1192118 [patent_doc_number] => 06730319 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-04 [patent_title] => 'Pharmaceutical compositions having depressed melting points' [patent_app_type] => B2 [patent_app_number] => 10/154554 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5278 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/730/06730319.pdf [firstpage_image] =>[orig_patent_app_number] => 10154554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519976 [patent_doc_number] => 20020192265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Food bars containing nutritional supplements and anti-constipation and regularity-maintaining agents' [patent_app_type] => new [patent_app_number] => 10/144641 [patent_app_country] => US [patent_app_date] => 2002-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13200 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192265.pdf [firstpage_image] =>[orig_patent_app_number] => 10144641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1282895 [patent_doc_number] => 06638524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-10-28 [patent_title] => 'Cosmetics, foods and beverages supplemented with purified strictinin' [patent_app_type] => B2 [patent_app_number] => 10/131211 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 4871 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638524.pdf [firstpage_image] =>[orig_patent_app_number] => 10131211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1260505 [patent_doc_number] => 06663889 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Ambroxol-containing lozenge' [patent_app_type] => B1 [patent_app_number] => 10/031580 [patent_app_country] => US [patent_app_date] => 2002-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1550 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/663/06663889.pdf [firstpage_image] =>[orig_patent_app_number] => 10031580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1380813 [patent_doc_number] => 06548080 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Method for partially demineralized cortical bone constructs' [patent_app_type] => B1 [patent_app_number] => 10/124424 [patent_app_country] => US [patent_app_date] => 2002-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 6291 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548080.pdf [firstpage_image] =>[orig_patent_app_number] => 10124424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1188559 [patent_doc_number] => 06733790 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-11 [patent_title] => 'Microcapsules and processes for making the same using various polymers and chitosans' [patent_app_type] => B1 [patent_app_number] => 10/018866 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12585 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/733/06733790.pdf [firstpage_image] =>[orig_patent_app_number] => 10018866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6864830 [patent_doc_number] => 20030190356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Process for preparing oral sustained-release formulation of felodipine' [patent_app_type] => new [patent_app_number] => 10/118690 [patent_app_country] => US [patent_app_date] => 2002-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3029 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190356.pdf [firstpage_image] =>[orig_patent_app_number] => 10118690 [rel_patent_id] =>[rel_patent_doc_number] =>)